Graduate Institute of Applied Science and Engineering, College of Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan.
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
J Ethnopharmacol. 2019 Apr 6;233:47-55. doi: 10.1016/j.jep.2018.12.035. Epub 2018 Dec 24.
Sijunzi decoction is a well-known traditional Chinese medicine (TCM) commonly used for invigorating vital energy and for the enhancement of immunity. Modified Sijunzi decoctions have been extensively used to treat cachexia and improve the quality of life of cancer patients undergoing chemotherapy.
This study was aimed to provide comprehensive evidence for the anti-cachectic effect of a modified Sijunzi decoction (Zhen-Qi; ZQ-SJZ) and characterize its anti-cachectic mechanism, especially in cisplatin-induced muscle atrophy.
We employed a Lewis lung carcinoma (LLC)-induced cancer cachectic mouse model to demonstrate the anti-cachectic effect of ZQ-SJZ. Moreover, we provided an in vitro C2C12 myotube formation model to investigate the effect of ZQ-SJZ in hampering cisplatin-induced muscle atrophy.
The administration of ZQ-SJZ can recover tumor- and/or cisplatin-induced body weight loss, intestinal mucosal damage, as well as forelimb grip strength and myofiber size. The administration of ZQ-SJZ also significantly prolonged the survival of LLC-induced cachectic mice under cisplatin treatment. Mechanistically, ZQ-SJZ increased the levels of myogenic proteins, such as myosin heavy chain (MyHC) and myogenin, and decreased the atrophy-related protein, atrogin-1, in cisplatin-treated C2C12 myotubes in vitro. In addition, cisplatin-induced mitochondria dysfunction could be hampered by the co-administration of ZQ-SJZ, by which it recovered the cisplatin-mediated decrease in PGC-1α and PKM1 levels.
The administration of ZQ-SJZ can recover tumor- and/or cisplatin-induced cachectic conditions and significantly prolong the survival of LLC-induced cachectic mice under cisplatin treatment. The profound effect of ZQ-SJZ in hampering tumor- and/or cisplatin-induced cachexia may be due to its modulation of the mitochondrial function and subsequent myogenesis. Taken together, these results demonstrated the anti-cachectic mechanism of ZQ-SJZ and its potential use as a palliative strategy to improve the efficacy of chemotherapy.
四君子汤是一种著名的中药(TCM),常用于补气和增强免疫力。改良的四君子汤已被广泛用于治疗恶病质,并提高接受化疗的癌症患者的生活质量。
本研究旨在为改良四君子汤(Zhen-Qi;ZQ-SJZ)的抗恶病质作用提供全面的证据,并探讨其抗恶病质机制,特别是在顺铂诱导的肌肉萎缩中。
我们采用Lewis 肺癌(LLC)诱导的癌性恶病质小鼠模型来证明 ZQ-SJZ 的抗恶病质作用。此外,我们提供了一个体外 C2C12 肌管形成模型来研究 ZQ-SJZ 抑制顺铂诱导的肌肉萎缩的作用。
ZQ-SJZ 的给药可以恢复肿瘤和/或顺铂引起的体重减轻、肠黏膜损伤以及前肢握力和肌纤维大小。ZQ-SJZ 的给药还显著延长了 LLC 诱导的恶病质小鼠在顺铂治疗下的存活时间。在机制上,ZQ-SJZ 增加了肌生成蛋白,如肌球蛋白重链(MyHC)和肌生成素的水平,并降低了体外顺铂处理的 C2C12 肌管中的萎缩相关蛋白 atrogin-1。此外,ZQ-SJZ 可以阻止顺铂诱导的线粒体功能障碍,通过恢复顺铂介导的 PGC-1α 和 PKM1 水平降低。
ZQ-SJZ 的给药可以恢复肿瘤和/或顺铂诱导的恶病质状态,并显著延长 LLC 诱导的恶病质小鼠在顺铂治疗下的存活时间。ZQ-SJZ 抑制肿瘤和/或顺铂诱导的恶病质的显著作用可能是由于其对线粒体功能的调节和随后的肌发生。综上所述,这些结果证明了 ZQ-SJZ 的抗恶病质机制及其作为改善化疗疗效的姑息治疗策略的潜力。